Whew let’s hope that were true. Let me just say anything is possible,, but lol. There’s a significant cost to ktra for Lincoln to commit to this kind of equity line agreement. Details should come in the 8k or 10q attachments. First hand witnessed one company battle out of this same boilerplate agreement and get less outrageous but still outraged financing. Someone at Torrey Hills Capital years back rated Lincoln lower than pond scum and they deal with every and all types of financiers. Still find it odd they can’t strike a contingent deal with any bio/pharma for $15-30 million to see them through if the drip is so sure fire as it appears to be by the presentation progress reports. Not my area of expertise just odd to me.
News 
Market Data 
Discover 
